PT -141 (Sexual & Hormonal Health)

What is it?
PT-141 (Bremelanotide) is a synthetic melanocortin peptide that acts directly on the central nervous system via melanocortin receptors to enhance sexual desire and arousal. Unlike traditional ED medications that work peripherally, PT-141 works centrally — addressing the neurological roots of low libido in both men and women. It has been FDA-approved for hypoactive sexual desire disorder (HSDD) in premenopausal women and is widely used off-label for male sexual dysfunction.

Who is it for?
PT-141 is designed for men and women experiencing low libido, reduced arousal, or intimacy challenges. It is suitable for those who have not responded to other approaches and those seeking a neurologically-targeted solution.

Key Benefits
• Increases sexual desire and arousal in men and women
• Works centrally via the brain — not just a vascular effect
• Effective for low libido unrelated to hormonal imbalance
• Supports men with ED who do not respond to PDE5 inhibitors
• FDA-approved as Vyleesi for women with HSDD
• Improves confidence and intimacy
• Works within 30–60 minutes of administration

What's Include?
• Personalized Peptide Protocol
• Prefilled Pen Delivery
• Guided Administration & Monitoring
• Progress Tracking